Cargando…
CSF Biomarkers for Alzheimer's Disease Diagnosis
Alzheimer's disease (AD) is the most common form of dementia that affects several million people worldwide. The major neuropathological hallmarks of AD are the presence of extracellular amyloid plaques that are composed of Aβ40 and Aβ42 and intracellular neurofibrillary tangles (NFT), which is...
Autores principales: | Anoop, A., Singh, Pradeep K., Jacob, Reeba S., Maji, Samir K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915796/ https://www.ncbi.nlm.nih.gov/pubmed/20721349 http://dx.doi.org/10.4061/2010/606802 |
Ejemplares similares
-
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
por: Haris, Mohammad, et al.
Publicado: (2015) -
CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023) -
Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity
por: Jha, Narendra Nath, et al.
Publicado: (2016) -
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022) -
Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
por: Zou, Kun, et al.
Publicado: (2020)